Skip to search formSkip to main contentSkip to account menu

cytarabine/daunorubicin/zosuquidar trihydrochloride

Known as: ARA-C/DNR/LY335979 
National Institutes of Health

Related topics

Related topics

3 relations
CytarabineDaunorubicin Hydrochloridezosuquidar trihydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Therapeutic use eslikarbazepina
1. Application eslikarbazepina or eslikarbazepina acetate for making a medicament for treating a condition selected from epilepsy… 
1999
1999
Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents
The multidrug transporter P-glycoprotein (Pgp), which is frequently overexpressed in multidrug resistant leukemia, has many… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)